Your browser doesn't support javascript.
loading
A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab Biosimilar.
Reinisch, Walter; Cohen, Stanley; Ramchandani, Monica; Khraishi, Majed; Liu, Jennifer; Chow, Vincent; Franklin, Janet; Colombel, Jean-Frederic.
Afiliación
  • Reinisch W; Division of Gastroenterology and Hepatology, Working Party Inflammatory Bowel Disease (IBD), Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
  • Cohen S; Metroplex Clinical Research, 8144 Walnut Hill Lane, Dallas, TX, USA.
  • Ramchandani M; Biosimilars, Amgen, One Amgen Center Dr., Thousand Oaks, CA, USA.
  • Khraishi M; Department of Medicine (Rheumatology), Memorial University of Newfoundland, St. John's, Canada.
  • Liu J; Nexus Clinical Research, St. John's, 189 Waterford Brdg, St. John's, NL, Canada.
  • Chow V; Biosimilars, Amgen, One Amgen Center Dr., Thousand Oaks, CA, USA.
  • Franklin J; Clinical Pharmacology, Amgen, One Amgen Center Dr., Thousand Oaks, CA, USA.
  • Colombel JF; Biosimilars, Amgen, One Amgen Center Dr., One Amgen Center Drive, Thousand Oaks, CA, 91320-1799, USA. janet.franklin@amgen.com.
Adv Ther ; 39(1): 44-57, 2022 01.
Article en En | MEDLINE | ID: mdl-34757601

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Biosimilares Farmacéuticos Límite: Humans Idioma: En Revista: Adv Ther Asunto de la revista: TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Biosimilares Farmacéuticos Límite: Humans Idioma: En Revista: Adv Ther Asunto de la revista: TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Austria